Israel Englander Arvinas, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Arvinas, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 200,199 shares of ARVN stock, worth $5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200,199

Previous 243,667 17.84%

Holding current value

$5 Million

Previous $10.1 Million 47.02%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $1.06 Million - $1.76 Million	-43,468 Reduced 17.84%	200,199 $5.33 Million
Q1 2024 May 15, 2024	SELL	$36.38 - $52.31 $4.19 Million - $6.02 Million	-115,146 Reduced 32.09%	243,667 $10.1 Million
Q4 2023 Feb 14, 2024	SELL	$14.19 - $42.33 $671,811 - $2 Million	-47,344 Reduced 11.66%	358,813 $14.8 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $3.53 Million - $5.1 Million	162,275 Added 66.54%	406,157 $10.1 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $4.86 Million - $6.93 Million	185,944 Added 320.94%	243,882 $6.66 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $2.17 Million - $3.83 Million	-66,867 Reduced 53.58%	57,938 $1.98 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $202,650 - $280,671	4,840 Added 4.03%	124,805 $5.55 Million
Q2 2022 Aug 15, 2022	SELL	$36.01 - $74.24 $4.98 Million - $10.3 Million	-138,299 Reduced 53.55%	119,965 $5.05 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $6.02 Million - $8.15 Million	99,964 Added 63.15%	258,264 $17.4 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $5.8 Million - $8.47 Million	88,044 Added 125.32%	158,300 $13 Million
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $4.18 Million - $6.15 Million	-57,036 Reduced 44.81%	70,256 $5.77 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $434,635 - $605,829	7,190 Added 5.99%	127,292 $9.8 Million
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $9.13 Million - $14.3 Million	-156,862 Reduced 56.64%	120,102 $7.94 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $3.32 Million - $14 Million	164,393 Added 146.03%	276,964 $23.5 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $2.4 Million - $3.79 Million	104,193 Added 1243.65%	112,571 $2.66 Million
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $3 Million - $5.7 Million	-100,447 Reduced 92.3%	8,378 $281,000
Q1 2020 May 14, 2020	SELL	$33.0 - $54.5 $4.68 Million - $7.73 Million	-141,791 Reduced 56.58%	108,825 $4.39 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $3.54 Million - $10.2 Million	229,858 Added 1107.32%	250,616 $10.3 Million
Q3 2019 Nov 14, 2019	BUY	$21.55 - $27.61 $447,334 - $573,128	20,758 New	20,758 $447,000
Q2 2019 Aug 14, 2019	SELL	$15.96 - $23.8 $249,390 - $371,898	-15,626 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$13.55 - $23.79 $883,067 - $1.55 Million	-65,171 Reduced 80.66%	15,626 $231,000
Q4 2018 Feb 14, 2019	SELL	$11.19 - $18.56 $757,842 - $1.26 Million	-67,725 Reduced 45.6%	80,797 $1.04 Million
Q3 2018 Nov 14, 2018	BUY	$16.05 - $16.87 $2.38 Million - $2.51 Million	148,522 New	148,522 $2.51 Million

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

68.6M

Call Options Held

166K

Put Options Held

31.3K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.33B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account